Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

about

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

Item

http://www.wikidata.org/entity/Q39161794

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Teneligliptin real-world effic ...... s in India (TREAT-INDIA study)

@en

Teneligliptin real-world effic ...... tes mellitus patients in India

@nl

type

Item

label

Teneligliptin real-world effic ...... s in India (TREAT-INDIA study)

@en

Teneligliptin real-world effic ...... tes mellitus patients in India

@nl

prefLabel

Teneligliptin real-world effic ...... s in India (TREAT-INDIA study)

@en

Teneligliptin real-world effic ...... tes mellitus patients in India

@nl

P1476

Teneligliptin real-world effic ...... s in India (TREAT-INDIA study)

@en

P2093

Debmalya Sanyal

http://www.w3.org/2001/XMLSchema#string

K D Modi

http://www.w3.org/2001/XMLSchema#string

Sandeep Kharb

http://www.w3.org/2001/XMLSchema#string

Shailesh Trivedi

http://www.w3.org/2001/XMLSchema#string

Sujoy Ghosh

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

10-year follow-up of intensive glucose control in type 2 diabetes

Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients

Teneligliptin as an initial therapy for newly diagnosed, drug naive subjects with type 2 diabetes

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

Prevalence of dyslipidemia and hypertension in Indian type 2 diabetic patients with metabolic syndrome and its clinical significance

Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE)

Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis.

P304

347-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DMSO.S121770

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27877058

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

India

P932

5108474

http://www.w3.org/2001/XMLSchema#string